Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 656

1.

Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data.

Boettiger DC, Law MG, Dore GJ, Guy R, Callander D, Donovan B, O'Connor CC, Fairley CK, Hellard M, Matthews G.

BMC Infect Dis. 2017 Dec 1;17(1):740. doi: 10.1186/s12879-017-2848-0.

2.

Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature.

Tang W, Chen W, Amini A, Boeras D, Falconer J, Kelly H, Peeling R, Varsaneux O, Tucker JD, Easterbrook P.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):695. doi: 10.1186/s12879-017-2773-2. Review.

3.

One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.

Parry JV, Easterbrook P, Sands AR.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):705. doi: 10.1186/s12879-017-2774-1.

4.

Systematic review with meta-analysis: performance of dried blood spots for hepatitis C antibodies detection.

Muzembo BA, Mbendi NC, Nakayama SF.

Public Health. 2017 Dec;153:128-136. doi: 10.1016/j.puhe.2017.08.008. Epub 2017 Oct 14. Review.

PMID:
29035801
5.

Hospital-visiting pregnant women signal an increased spread of hepatitis C infection in Khyber Pakhtunkhwa region of Pakistan.

Afsheen Z, Ahmad B, Bashir S.

Virol J. 2017 Oct 10;14(1):195. doi: 10.1186/s12985-017-0861-y.

6.

Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics.

Hossain N, Puchakayala B, Kanwar P, Verma S, Abraham G, Ivanov Z, Niaz MO, Mohanty SR.

Dig Dis Sci. 2017 Nov;62(11):3193-3199. doi: 10.1007/s10620-017-4754-0. Epub 2017 Sep 14.

PMID:
28913613
7.

Performance of rapid diagnostic tests for detection of Hepatitis B and C markers in HIV infected patients.

Barbosa JR, Colares JKB, Flores GL, Cortes VF, Miguel JC, Portilho MM, Marques VA, Potsch DV, Brandão-Mello CE, Amendola-Pires M, Pilotto JH, Lima DM, Lampe E, Villar LM.

J Virol Methods. 2017 Oct;248:244-249. doi: 10.1016/j.jviromet.2017.08.001. Epub 2017 Aug 4.

PMID:
28782578
9.

Use and acceptability of salivary hepatitis C virus testing in an English Young Offender Institution.

Candfield S, Samuel MI, Ritchie D, McDonald C, Brady M, Taylor C.

Int J STD AIDS. 2017 Oct;28(12):1234-1238. doi: 10.1177/0956462417696214. Epub 2017 Mar 3.

PMID:
28632479
10.

Hepatitis C among blood donors: cascade of care and predictors of loss to follow-up.

Machado SM, Almeida C Neto, Pinho JRR, Malta FM, Capuani L, Campos AF, Abreu FRM, Nastri ACSS, Santana RAF, Sabino EC, Mendes-Correa MC.

Rev Saude Publica. 2017 Apr 27;51(0):40. doi: 10.1590/S1518-8787.2017051006468.

11.

Promoting notification and linkage of HBs antigen and anti-HCV antibody-positive patients through hospital alert system.

Yoshioka N, Okumura A, Yamamoto Y, Yamaguchi K, Kaga A, Yamada K, Hirosaki T, Ishikawa D, Kunii S, Watanabe K, Utsunomiya S, Hayashi K, Ishigami M, Goto H, Hirooka Y.

BMC Infect Dis. 2017 May 8;17(1):330. doi: 10.1186/s12879-017-2438-1.

12.

[The Clinical Significance of Serum Alpha-fetoprotein in Diagnosing Hepatocellular Carcinoma in a Health Screening Population].

Ko YS, Bae JH, Sinn DH, Gwak GY, Kang W, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Korean J Gastroenterol. 2017 Apr 25;69(4):232-238. doi: 10.4166/kjg.2017.69.4.232. Korean.

13.

Threshold value of LIAISON XL anti-HCV screening assay predicting positive immunoblotting results.

De Paschale M, Manco MT, Arpino O, Ricucci V, Paganini A, Belvisi L, Cagnin D, Cerulli T, Cianflone A, Agrappi C, Mirri P, Clerici P.

J Med Virol. 2017 Oct;89(10):1817-1822. doi: 10.1002/jmv.24831. Epub 2017 May 23.

PMID:
28401710
14.

Diagnostic Dilemmas in Hepatitis C Virus Infection for Hemodialysis Patients.

Komitova RT, Atanasova MV, Pavlova TA, Nyagolov MS, Ivanova AV.

Folia Med (Plovdiv). 2017 Mar 1;59(1):70-77. doi: 10.1515/folmed-2017-0012.

PMID:
28384106
15.

Transfusion transmitted infections in frequently transfused thalassemic children living in Fayoum Governorate, Egypt: Current prevalence and risk factors.

Atwa ZT, Abdel Wahed WY.

J Infect Public Health. 2017 Nov - Dec;10(6):870-874. doi: 10.1016/j.jiph.2017.02.012. Epub 2017 Mar 11.

16.

[Seroprevalence of viral markers among blood donors at the Blood Donor Center of Mohammed V Military Teaching Hospital of Rabat, Morocco].

Uwingabiye J, Zahid H, Unyendje L, Hadef R.

Pan Afr Med J. 2016 Nov 24;25:185. doi: 10.11604/pamj.2016.25.185.6266. eCollection 2016. French.

17.

Retrospective analysis on the diagnostic performances and signal-to-cut-off ratios of the Elecsys Anti-HCV II assay.

Kim B, Ahn HJ, Choi MH, Park Y.

J Clin Lab Anal. 2018 Jan;32(1). doi: 10.1002/jcla.22165. Epub 2017 Feb 10.

PMID:
28187227
18.

Hepatitis C Antibody Testing in a Commercially Insured Population, 2005-2014.

Isenhour CJ, Hariri SH, Hales CM, Vellozzi CJ.

Am J Prev Med. 2017 May;52(5):625-631. doi: 10.1016/j.amepre.2016.12.016. Epub 2017 Feb 1.

PMID:
28161033
19.

Uptake of hepatitis C screening, characteristics of patients tested, and intervention costs in the BEST-C study.

Brady JE, Liffmann DK, Yartel A, Kil N, Federman AD, Kannry J, Jordan C, Massoud OI, Nerenz DR, Brown KA, Smith BD, Vellozzi C, Rein DB.

Hepatology. 2017 Jan;65(1):44-53. doi: 10.1002/hep.28880. Epub 2016 Nov 25.

20.

Reflex threshold of signal-to-cut-off ratios of the Elecsys anti-HCV II assay for hepatitis C virus infection.

Pan J, Li X, He G, Yuan S, Feng P, Zhang X, Qiu Y.

J Infect Dev Ctries. 2016 Sep 30;10(9):1031-1034. doi: 10.3855/jidc.7301.

Supplemental Content

Loading ...
Support Center